These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24851270)

  • 1. Osteoblasts protect AML cells from SDF-1-induced apoptosis.
    Kremer KN; Dudakovic A; McGee-Lawrence ME; Philips RL; Hess AD; Smith BD; van Wijnen AJ; Karp JE; Kaufmann SH; Westendorf JJ; Hedin KE
    J Cell Biochem; 2014 Jun; 115(6):1128-37. PubMed ID: 24851270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-Nonspecific Alkaline Phosphatase Is Required for MC3T3 Osteoblast-Mediated Protection of Acute Myeloid Leukemia Cells from Apoptosis.
    Sterner RM; Kremer KN; Dudakovic A; Westendorf JJ; van Wijnen AJ; Hedin KE
    J Immunol; 2018 Aug; 201(3):1086-1096. PubMed ID: 29914885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts.
    Kremer KN; Dudakovic A; Hess AD; Smith BD; Karp JE; Kaufmann SH; Westendorf JJ; van Wijnen AJ; Hedin KE
    J Biol Chem; 2015 Dec; 290(49):29478-92. PubMed ID: 26491017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak.
    Kremer KN; Peterson KL; Schneider PA; Meng XW; Dai H; Hess AD; Smith BD; Rodriguez-Ramirez C; Karp JE; Kaufmann SH; Hedin KE
    J Biol Chem; 2013 Aug; 288(32):22899-914. PubMed ID: 23798675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
    Zeng Z; Shi YX; Samudio IJ; Wang RY; Ling X; Frolova O; Levis M; Rubin JB; Negrin RR; Estey EH; Konoplev S; Andreeff M; Konopleva M
    Blood; 2009 Jun; 113(24):6215-24. PubMed ID: 18955566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells.
    Hosogane N; Huang Z; Rawlins BA; Liu X; Boachie-Adjei O; Boskey AL; Zhu W
    Int J Biochem Cell Biol; 2010 Jul; 42(7):1132-41. PubMed ID: 20362069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
    Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
    Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4
    Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
    Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells.
    Zhu W; Boachie-Adjei O; Rawlins BA; Frenkel B; Boskey AL; Ivashkiv LB; Blobel CP
    J Biol Chem; 2007 Jun; 282(26):18676-85. PubMed ID: 17439946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of CXCR4/STAT3 in mesenchymal stromal cell-mediated drug resistance of acute leukemia cells].
    Tang Y; Guo Q; Zhi Y; Jin X; Xia B; Guo S; Tian C; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):119-23. PubMed ID: 27014981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal-derived factor-1 deficiency in the bone marrow of acute myeloid leukemia.
    Ge J; Hou R; Liu Q; Zhu R; Liu K
    Int J Hematol; 2011 Jun; 93(6):750-759. PubMed ID: 21607655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migratory behavior of leukemic cells from acute myeloid leukemia patients.
    Voermans C; van Heese WP; de Jong I; Gerritsen WR; van Der Schoot CE
    Leukemia; 2002 Apr; 16(4):650-7. PubMed ID: 11960346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
    Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
    Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
    Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
    Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L
    Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
    Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
    J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.
    Zeng Z; Shi YX; Tsao T; Qiu Y; Kornblau SM; Baggerly KA; Liu W; Jessen K; Liu Y; Kantarjian H; Rommel C; Fruman DA; Andreeff M; Konopleva M
    Blood; 2012 Sep; 120(13):2679-89. PubMed ID: 22826565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of microRNA-149 activates SDF-1/CXCR4 to promote osteogenic differentiation of mesenchymal stem cells.
    Li G; An J; Han X; Zhang X; Wang W; Wang S
    J Cell Physiol; 2019 Dec; 234(12):23485-23494. PubMed ID: 31206187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.
    Tavor S; Eisenbach M; Jacob-Hirsch J; Golan T; Petit I; Benzion K; Kay S; Baron S; Amariglio N; Deutsch V; Naparstek E; Rechavi G
    Leukemia; 2008 Dec; 22(12):2151-5158. PubMed ID: 18769446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.
    Frisch BJ; Ashton JM; Xing L; Becker MW; Jordan CT; Calvi LM
    Blood; 2012 Jan; 119(2):540-50. PubMed ID: 21957195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.